IN VIVO SCIENTIFIC & COMMERCIAL TRIALS
DONE WITH MYCO-AD®

SCIENTIFIC TRIAL IN VIVO
MYCO-AD® VS AFLATOXIN B1, 7.5 PPM WITH BROILERS

EXPERIMENTAL PROTOCOL

1. Animal: Broilers
2. Age: 4 days
3. Length: 20 days
4. Repetitions: 24 per treatment
5. Basic diet: Sorghum, iso-caloric, iso-protein, iso-lysine soy, and with the same zurfacted AAC levels
6. Mycotoxin: Aflatoxin B1, SIGMA LABS, USA
7. MYCO-AD® Standard dosage of 2.5 kg / ton

TREATMENT

INITIAL WEIGHT
gr

FINAL WEIGHT
gr

CONSUMPTION
gr / day

GAIN
gr / day

FEED CONVERSION

CONTROL

78.87 a

639.47 a

45.90 a

28.03 a

1.637 a

CONTROL + MYCO-AD®

78.35 a

634.95 a

47.82 a

27.83 a

1.717 a

CONTROL + AF

76.71 a

446.51 b

35.42 b

18.49 b

1.915 b

CONTROL + AF + MYCO-AD®

78.90 a

608.50 a

43.01 c

26.48 a

1.623 a

PROBABILITY

P < 0.052

P < 0.0001

P < 0.001

P < 0.001

P < 0.01

(*) Different subscripts on a column indicate statistically significant differences


SCIENTIFIC TRIAL IN VIVO
MYCO-AD® VS OCHRATOXIN A, 2.0 PPM IN BROILERS

EXPERIMENTAL PROTOCOL

1. Animal: Broilers
2. Age: 7 days
3. Length: 20 days
4. Repetitions: 16 per treatment
5. Basic diet: Sorghum, iso-caloric, iso-protein, iso-lysine soy, and with the same zurfacted AAC levels
6. Mycotoxin: Ochratoxin A, SIGMA LABS, USA
7. MYCO-AD® Standard dosage of 2.5 kg / ton

TREATMENT

INITIAL WEIGHT
gr

FINAL WEIGHT
gr

CONSUMPTION
gr / day

GAIN
gr / day

FEED CONVERSION

CONTROL

82.45 a

734.5 a

53.87 a

31.05 a

1.734 a

CONTROL + MYCO-AD®

85.36 a

738.8 a

54.85 a

31.12 a

1.762 a

CONTROL + OC

82.63 a

705.5 a

52.91 a

29.67 b

1.783 a

CONTROL+OC + MYCO-AD®

85.19 a

770.4 a

53.89 a

32.63 a

1.651 b

PROBABILITY

P < 0.05

P < 0.05

P < 0.57

P < 0.05

P < 0.05

(*) Different subscripts on a column indicate statistically significant differences



COMPARATIVE SCIENTIFIC TRIAL IN VIVO
MYCO-AD® VS PRODUCT "X" AND AFLATOXIN B1, 5.00 PPM WITH BROILERS

EXPERIMENTAL TRIAL

1. Animal: Broilers
2. Age: 11 days
3. Length: 16 days
4. Repetitions: 10 per treatment
5. Basic diet: Sorghum, iso-caloric, iso-protein, iso-lysine soy, and with the same surfacted AAC levels
6. Mycotoxin: Aflatoxin B1, SIGMA LABS, USA
7. MYCO-AD® Standard dosage of 2.5 kg / ton
8. Product "X" Dosage 2.5 kg / ton

TREATMENT

INITIAL WEIGHT
gr

FINAL WEIGHT
gr

CONSUMPTION
gr / day

GAIN
gr / day

FEED CONVERSION

CONTROL

258.7 a

845.3 a

68.82 a

41.44 a

1.680 a

CONTROL + MYCO-AD®

256.0 a

863.4 a

67.75 a

40.48 a

1.673 a

CONTROL + PRODUCT "x"

255.9 a

837.9 a

67.89 a

38.87 a

1.746 a

CONTROL + AF

256.6 a

828.6 b

68.96 a

38.24 a

1.803 b

CONTROL + AF + MYCO-AD®

255.3 a

893.0 a

71.37 b

42.48 a

1.680 a

CONTROL + AF + PRODUCT "x"

252.4 a

822.7 b

69.26 a

38.01 b

1.822 b

PROBABILITY

P < 0.05

P < 0.05

P < 0.05

P < 0.05

P < 0.05

(*) Different subscripts on a column indicate statistically significant differences


MYCO-AD® VS PRODUCT "X", CARCASS YIELD

TREATMENT

LEG YIELD %

MUSCLE YIELD %

BREAST YIELD %

CONTROL

4.28 a

4.15 a

14.52 a

CONTROL + MYCO-AD®

4.18 a

4.18 a

14.52 a

CONTROL + PRODUCT "x"

4.19 a

4.47 a

14.94 a

CONTROL + AF

4.12 a

4.05 a

14.44 a

CONTROL + AF + MYCO-AD®

5.75 b

5.43 b

18.46 b

CONTROL + AF + PRODUCT "x"

3.86 a

3.72 a

12.98 a

PROBABILITY

P < 0.05

P < 0.05

P < 0.05

(*) Different subscripts on a column indicate statistically significant differences



COMMERCIAL TRIAL

BROILER FEED CONTAINING 2 ppm T-2


Place: Mayor Mexican Poultry Integrator
Type of animal: Broilers
Disease: Mycotoxicosis by Trichothecenes at 2 ppm (T-2, DAS ... etc)
Trial start: 4th week: when 100% of the birds had oral lesions
Dosage MYCO-AD® was added at 2.5 kg / ton

COMPARATIVE COMMERCIAL TRIAL WITH COMMERCIAL FEED
MYCO-AD® VS A COMMERCIAL ALUMINOSILICATE IN BROILERS


In a field trial performed in Guerrero (México), where MYCO-AD® at 2.5 kg / ton of feed was compared to a commercial aluminosilicate at 5 kg / ton of feed, feeding commercial broiler flocks from 1 to 56 days of age, under a clinical suspicions of exposure to mycotoxins, the following was found:

PRODUCTIVE RESULTS OF BROILER FLOCKS TREATED WITH MYCO-AD® AND ANOTHER COMMERCIAL ALUMINOSILICATE

ZOOTECHNICAL PARAMETERS
8th week

MYCO-AD® 2.5 kg / ton

ALUMINOSILICATE
5.0 kg / ton

MORTALITY

10.78 %

11.55 %

FEED CONVERSION

2.39

2.44

FINAL WEIGHT

2.570 kg

2.240 kg

DAILY GAIN

45.89 g

40.0 g

PRODUCTIVITY INDEX

175

156


COMPARATIVE SCIENTIFIC TRIAL WITH COMMERCIAL FEED
WITH AFLATOXIN 100 / 140 PPB AND T2 100 / 150 PPB IN LAYERS

Three groups of 100 white Babcock layers, 30 weeks of age, housed under commercial conditions, were given MYCO-AD® at a 2.5 kg / ton of feed, a synthetic aluminum silicate at 1.0 Kg / ton and a group was used as non medicated control. The commercial feed contained 100 to 140 ppb of aflatoxin and 100 to 150 ppb of T2. After 19 days of trial, statistical analysis of the results were performed:

MYCO-AD VS SYNTHETIC ALUMINOSILICATE IN LAYERS

GROUP

EGG WEIGHT
gr

PRODUCTION
%

EGG MASS
kg

FEED CONVERSION

CONTROL

56.9 a

88.4 a

95.5 a

2.161 a

MYCO-AD®

58.4 b

93.2 b

103.4 b

2.000 b

SYNTHETIC

55.9 a

90.5 a

96.0 a

2.126 a

PROBABILITY

P < 0.05

P < 0.05

P < 0.05

P < 0.05

(*) Different subscripts on a column indicate statistically significant differences




SCIENTIFIC TRIAL WITH COMMERCIAL FEED
TO PROVE THAT MYCO-AD® DOES NOT ABSORB NUTRIENTS

Trial performed at CEIEPA, FMVZ, UNAM, using a fully random design, with 432 Isa Babcock B-300 Layers, 30 weeks of age, housed in cages of 3 each, 2 treatments, were used with 6 repetitions of 12 layers each. The following treatments were provided: control base diet, base diet + MYCO-AD® at 2.5 kg / Mt, and the following results were obtained:

MYCO-AD® IN LAYERS WITH NO EXPOSURE TO MYCOTOXINS

TREATMENT

LAYING
%

EGG WEIGHT
gr

CONSUMPTION
gr

FEED CONV

BIRD / DAY
MASS
gr

HAUGH UNIT

SHELL WITH
mm

CONTROL

82.5 a

61.5 a

104.2 a

2.075 a

50.8 a

90.67 a

0.322 a

MYCO-AD®

81.8 a

60.9 a

103.1 a

2.073 a

49.8 a

89.13 a

0.325 a

PROBABILITY

P < 0.05

P < 0.05

P < 0.05

P < 0.05

P < 0.05

P < 0.05

P < 0.05

(*) Different subscripts on a column indicate statistically significant differences


SCIENTIFIC TRIAL
1 PPM OF T-2 IN BROILERS VS
. MYCO-AD®

TREATMENT

INITIAL
WEIGHT

FINAL
WEIGHT

DAILY
CONSUMPTION

AVERAGE
DAILY WEIGHT

FEED CONSUMPTION

Control

42 a

1791 a

95 a

43,73 a

2,12 a

Control + 1 ppm T2

41 a

138 lb

75 b

33,50 b

2,17 a

Control +1 ppm T-2 + 2.5 kg Myco-Ad

42 a

1840 a

95 a

44,95 a

2,06 a

Probability

P <0.05

P<0.05

P<0.05

P<0.05

P<0.05

(*) Different subscripts in a column indicates statistically significant difference.

Institute of Veterinary Medicine, Debrecen, Hungary, 1999



ORAL LESIONS



SEVERITY OF ORAL LESIONS

Group II
per day

0

21

28

35

40

Negative

25

3

3

11

18

+

0

6

10

6

4

++

0

8

4

2

1

+++

0

8

7

4

0

Group II
per day

0

21

28

35

40

Negative

25

18

20

22

23

+

0

5

3

1

0

++

0

2

1

0

0

+++

0

0

0

0

0


SKELETON DISORDER / % /

RESULTS AT THE END OF THE TRIAL:
The presence of T-2 (Group II) caused:

Less body weight by 23 %
• Less feed consumption by 21 %
• Necrosis of the mucous and skin of the oral cavity
• Atrophy of the Limphotic organs by 25 % to 50 %
• In groups I y II there were problems in the feet in 18 % of the birds.

SCIENTIFIC TRIAL
MYCO-AD® VS 50 PPB OF AFLATOXIN B1 IMMUNOSUPRESION
LOW TITERS IN BROILERS

Control

28 days

35 days

42 days

50 ppb Afla

20.2 gmt

17.6 gmt.

15.2 gmt.

Myco-Ad® 50 ppb Afla

35.2 gmt

41.6 gmt.

46.4 gmt.

Control

Yield or gain

Consumption

FCR

Control 50 ppb Afla

1726.7 gr

3930

227

Control + Myco-Ad® + 50 ppb Afla

1861.7 gr

3976

213

Pakistan, 1999

 

SCIENTIFIC TRIAL
MYCO-AD® IN SWINE PRODUCTION

T1
T2
T3

Control with MB

Myco-Ad®

Commercial MB

Nº of animals/ treatment

48

48

48

Nº of replicas/ treatment

4

4

4

Male/Female ratio

24/24

24/24

24/24

Days of feeding

40

40

40

Average (Avg) initial weight (wt/kg)

26.47

27

26.62

Avg. Final wt

49.81

50.51

49.91

Average change in body wt (kg)

23.34

23.51

23.29

Avg, daily gain (grams)

583.5

587.75

582.25

Avg. Feed consumption(kg)

1.48 a

1.44 c

1.45 b

Avg. Feed Conversion

2.54

245

2.49

COST BENEFIT

Cost of HSM (in Pesos)

8.47

8.66

8.68

Feed Efficiency

2.54

2.45

2.49

Cost of pork kg/gain

21.51

21.21

21.61

Savings/ kg gain vs. control

0

0.3

-0.1

The levels of mycotoxins were 47 ppb of Aflatoxin, 8 ppb of Ochratoxin, 5 ppb of T-2 and 125 ppb of Zearalenone.

(1)Phillippines, 1999
Means with different superscripts are significantly different (<P0.05)

 

REDUCTION OF AFLATOXIN M1
IN MILK BY USING MYCO-AD®

Place: Italy
Customer: World known Feed Manufacturer

The European regulations admit only a maximum of 50 ppt of Aflatoxin M1 in Milk. This means that the level of Aflatoxin in feed should be a maximum of 5 ppb.

Due to Silage problems this year the contamination of Aflatoxin has been much higher than the normal. Also the government is now emphasizing checking the levels of Aflatoxin M1 in milk.

The total amount of cows in this trial were 800 before the administration of MYCO-AD®. The levels of M1 were between 75 to 60 ppt which are above the levels allowed by the European Common Market.

The treatment with MYCO-AD® at 50 grams/head per day started on April 17th, 1999, and the results of reduction were seen immediately. Throughout the rest of the trial the levels of M1 were below the maximum levels allowed, so the milk was in accordance to regulations.

Reduction of Aflatoxin M1 in Milk by Using Myco-Ad

During the trial the Nutritionist also observed that there was a big relationship between the level of M1 and the somatic cells count. The higher the M1 the higher the somatic cells count. Because of this, even at low levels of Aflatoxin 5 ppb it was affecting the animal immune system.

< PREVIOUS SECTION
MAIN MENU